Immunotherapy Approaches in Unresectable Stage III NSCLC: Whats on the Horizon?
Host: Jhanelle E. Gray, MD
\n\n\n \n
In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.